
InflaRx NV
NASDAQ:IFRX

Intrinsic Value
The intrinsic value of one
IFRX
stock under the Base Case scenario is
0.59
USD.
Compared to the current market price of 0.85 USD,
InflaRx NV
is
Overvalued by 30%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
InflaRx NV
Loading...
Fundamental Analysis


Revenue & Expenses Breakdown
InflaRx NV
Balance Sheet Decomposition
InflaRx NV
Current Assets | 85.6m |
Cash & Short-Term Investments | 65.9m |
Receivables | 1.7m |
Other Current Assets | 18.1m |
Non-Current Assets | 1.4m |
Long-Term Investments | 237.7k |
PP&E | 905.7k |
Intangibles | 54.1k |
Other Non-Current Assets | 191k |
Free Cash Flow Analysis
InflaRx NV
EUR | |
Free Cash Flow | EUR |
Earnings Waterfall
InflaRx NV
Revenue
|
130.2k
EUR
|
Cost of Revenue
|
-284.9k
EUR
|
Gross Profit
|
-154.7k
EUR
|
Operating Expenses
|
-53.4m
EUR
|
Operating Income
|
-53.5m
EUR
|
Other Expenses
|
8.8m
EUR
|
Net Income
|
-44.7m
EUR
|
IFRX Profitability Score
Profitability Due Diligence
InflaRx NV's profitability score is 16/100. The higher the profitability score, the more profitable the company is.

Score
InflaRx NV's profitability score is 16/100. The higher the profitability score, the more profitable the company is.
IFRX Solvency Score
Solvency Due Diligence
InflaRx NV's solvency score is 55/100. The higher the solvency score, the more solvent the company is.

Score
InflaRx NV's solvency score is 55/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
IFRX Price Targets Summary
InflaRx NV
According to Wall Street analysts, the average 1-year price target for
IFRX
is 4.37 USD
with a low forecast of 2.02 USD and a high forecast of 10.5 USD.
Dividends
Current shareholder yield for IFRX is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
IFRX
stock under the Base Case scenario is
0.59
USD.
Compared to the current market price of 0.85 USD,
InflaRx NV
is
Overvalued by 30%.